2006
DOI: 10.1016/j.ijpharm.2005.11.025
|View full text |Cite
|
Sign up to set email alerts
|

Self-assembled drug delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
2
2

Relationship

3
6

Authors

Journals

citations
Cited by 63 publications
(18 citation statements)
references
References 46 publications
0
18
0
Order By: Relevance
“…Using this technology, we may overcome the above-mentioned disadvantages of traditional carriers, and produce the nanoparticulate systems having high drug loads without drug leakage. Self-assembled nanoparticulate systems of prodrugs are called self-assembled drug delivery systems (SADDS) [13]. Significantly, self-assembling prodrugs are the basis of this technology.…”
Section: Introductionmentioning
confidence: 99%
“…Using this technology, we may overcome the above-mentioned disadvantages of traditional carriers, and produce the nanoparticulate systems having high drug loads without drug leakage. Self-assembled nanoparticulate systems of prodrugs are called self-assembled drug delivery systems (SADDS) [13]. Significantly, self-assembling prodrugs are the basis of this technology.…”
Section: Introductionmentioning
confidence: 99%
“…The degradation was much faster that in the buffered solutions and plasma. The presence of a great number of hydrolysis enzymes in the tissues may be the reason [24]. More importantly, the rapid degradation of CEPZ in the MPS was very preferred because the macrophages were the hosts of HIV.…”
Section: Degradation In Biological Samplesmentioning
confidence: 99%
“…Self-assembled drug delivery systems (SADDS) have been explored in our lab since 2001, defined as the self-assemblies of amphiphilic prodrugs, wherein three technologies involving prodrug, molecular self-assembly and nanotechnology are integrated [24]. Compared to traditional drug carriers, SADDS can deliver themselves in vivo with the unique advantages of high drug loads, no drug leakage, and controlled drug release at the targets.…”
Section: Introductionmentioning
confidence: 99%
“…Depending upon the chemical structure of the drug-lipid complex they may exist as ultrafine vesicular, micellar, or hexagonal aggregates. As the system is formed by linking a drug (pharmakon) to a carrier (soma), they are termed as "pharmacosomes" 11 . They are an effective tool to achieve desired therapeutic goals such as drug targeting and controlled release.…”
Section: Issn: 0975-8232mentioning
confidence: 99%